HORMONAL AND IMMUNOLOGICAL CHARACTERIZATION OF THE 32 KILODALTON OVARIAN-SPECIFIC PROTEIN

被引:17
|
作者
PARMER, TG [1 ]
MCLEAN, MP [1 ]
DUAN, WR [1 ]
NELSON, SE [1 ]
ALBARRACIN, CT [1 ]
KHAN, I [1 ]
GIBORI, G [1 ]
机构
[1] UNIV ILLINOIS, COLL MED, DEPT PHYSIOL & BIOPHYS, 835 S WOLCOTT, CHICAGO, IL 60612 USA
关键词
D O I
10.1210/en.131.5.2213
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent studies from this laboratory have shown that the large luteal cell of the pregnant rat contains an abundant 32 kilodalton (32K) phosphoprotein which is up-regulated by estradiol. In order to assess the potential importance of this protein and to more fully understand its function, a specific polyclonal antibody was produced against the 32K and was used to examine its intraovarian localization, its tissue specificity, and its developmental regulation. Immunocytochemical localization of the 32K in the ovary of the pregnant rat found this protein to be selectively and abundantly expressed in the corpus luteum. Immunofluorescence study of small and large luteal cell populations clearly revealed an extensive localization of the 32K in the large luteal cells. Western blot analysis revealed that the 32K was absent from all steroidogenic and nonsteroidogenic tissues. Whereas this protein was absent from all other tissues examined in the rat, it was clearly expressed in corpora lutea of different animal species, including the mouse, hamster, cow, human, and pig. Although undetectable by immunohistochemistry, Western blot analysis showed this protein to be present in the follicle but at levels markedly lower than in the corpus luteum. Analysis of theca and granulosa cells revealed the presence of the 32K in both cell types. To further examine the developmental expression of this protein throughout gestation, Western blot analysis of microsomal fractions isolated from rat corpora lutea on days 3-21 of pregnancy was performed. The 32K was detected at low levels in early pregnancy, increased markedly on day 11, reached a peak on days 14-15, and remained elevated through day 21. Treatment with estradiol and PRL increased the content of the 32K in the corpus luteum. Human CG, known to cause follicular development to the preovulatory stage and to enhance luteal estradiol synthesis, also increased levels of the 32K in the corpus luteum, while it concomitantly decreased this protein in the follicle. In summary, the presence of a unique ovarian-specific 32 kilodalton protein has been established. This protein, which is present in low abundance in theca and granulosa cells, is localized to the large luteal cell and becomes abundantly expressed during midpregnancy, a time when there is a remarkable increase in luteal cell size and activity. Results of this study also demonstrate a multihormonal regulation of the 32K by tropic hormones. Thus, because of its apparent uniqueness and its timely and highly regionalized expression, the 32K may play a central role in the regulation of corpus luteum growth and function.
引用
收藏
页码:2213 / 2221
页数:9
相关论文
共 50 条
  • [1] Cloning and characterization of an ovarian-specific protein that associates with the short form of the prolactin receptor
    Duan, WR
    Linzer, DIH
    Gibori, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (26) : 15602 - 15607
  • [2] INTERACTION OF AN OVARIAN-SPECIFIC PROTEIN WITH THE SHORT-FORM OF THE PROLACTIN RECEPTOR
    DUAN, WR
    FALISZEK, J
    LINZER, DIH
    GIBORI, G
    BIOLOGY OF REPRODUCTION, 1995, 52 : 145 - 145
  • [3] DEVELOPMENTAL REGULATION OF OVARIAN-SPECIFIC MOS EXPRESSION
    KESHET, E
    ROSENBERG, MP
    MERCER, JA
    PROPST, F
    VANDEWOUDE, GF
    JENKINS, NA
    COPELAND, NG
    ONCOGENE, 1988, 2 (03) : 235 - 240
  • [4] Characterization of novel ovarian-specific genes identified by serial analysis of gene expression (SAGE)
    Rangel, L
    Sherman-Baust, CA
    Schwartz, DR
    Cho, KR
    Morin, PJ
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 241A - 241A
  • [5] Bioengineering an Ovarian-Specific ECM Hydrogel to Treat Premature Ovarian Failure
    Frances-Herrero, Emilio
    Bueno-Fernandez, Clara
    Buigues, Anna
    Rodriguez-Eguren, Adolfo
    Gomez-Alvarez, Maria
    Faus, Amparo
    Herraiz, Sonia
    Pellicer, Antonio
    Cervello, Irene
    REPRODUCTIVE SCIENCES, 2023, 30 : 54A - 54A
  • [6] Targeted gene therapy of ovarian cancer using an ovarian-specific promoter
    Bao, RD
    Selvakumaran, M
    Hamilton, TC
    GYNECOLOGIC ONCOLOGY, 2002, 84 (02) : 228 - 234
  • [7] Cloning and transcriptional activity of ovarian-specific promoter in dairy goats
    Bai, Long
    Liu, Xueqing
    Fang, Fang
    Zhang, Liang
    Zhao, HaiBo
    Peng, Jiayin
    Cao, Binyun
    THERIOGENOLOGY, 2013, 80 (09) : 1067 - 1073
  • [8] Ovarian-Specific Extracellular Vesicles: A Novel Approach for Treating Premature Ovarian Insufficiency.
    Ghasroldasht, Mohammad Mousaei
    Ali, Farzana Liakath
    Park, Hang-Soo
    Al-Hendy, Ayman
    REPRODUCTIVE SCIENCES, 2024, 31 : 105A - 106A
  • [9] Immunological characterization of a recombinant 27-kilodalton antigenic protein from Paracoccidioides brasiliensis
    Ortiz, BL
    Garcia, AM
    Restrepo, A
    McEwen, JG
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1996, 3 (02) : 239 - 241
  • [10] ISOLATION AND IMMUNOLOGICAL CHARACTERIZATION OF A 55-KILODALTON SURFACE PROTEIN FROM SALMONELLA-TYPHIMURIUM
    FOULAKI, K
    GRUBER, W
    SCHLECHT, S
    INFECTION AND IMMUNITY, 1989, 57 (05) : 1399 - 1404